Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial-Reference-Cited by-同舟云学术

Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial

Published:2018-09-01 Issue:9 Volume:3 Page:806
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Nicholls Stephen J.¹²,Puri Rishi²,Ballantyne Christie M.³⁴,Jukema J. Wouter⁵,Kastelein John J. P.⁶,Koenig Wolfgang⁷⁸⁹,Wright R. Scott¹⁰,Kallend David¹¹,Wijngaard Peter¹¹,Borgman Marilyn²,Wolski Kathy²,Nissen Steven E.²

Affiliation:

1. South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia

2. Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research, Cleveland, Ohio

3. Section of Cardiovascular Research, Baylor College of Medicine, Houston, Texas

4. Methodist DeBakey Heart and Vascular Center, Houston, Texas

5. Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands

6. Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

7. Deutsches Herzzentrum München, Technische Universität München, Munich, Germany

8. Deutsches Zentrum für Herz-Kreislauf-Forschung E.V., partner site Munich Heart Alliance, Munich, Germany

9. Department of Internal Medicine, University of Ulm Medical Center, Ulm, Germany

10. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota

11. The Medicines Company, Parsippany, New Jersey

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. The forgotten majority: unfinished business in cardiovascular risk reduction.;Libby;J Am Coll Cardiol,2005

2. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.;Gordon;Circulation,1989

3. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.;Barter;N Engl J Med,2007

4. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.;Nicholls;Arterioscler Thromb Vasc Biol,2005

5. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.;Badimon;J Clin Invest,1990

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease;Current Opinion in Endocrinology, Diabetes & Obesity;2024-08-05

2. CSL112 and HDL function hypothesis – a never-ending wait;Expert Review of Clinical Pharmacology;2024-07-15

3. Looking Under the Hood of the “Good” Cholesterol;JACC: Heart Failure;2024-07

4. Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI;Journal of the American College of Cardiology;2024-06

5. New targets and mechanisms of action for lipid-lowering and anti-inflammatory therapies in atherosclerosis: where does the field stand?;Expert Opinion on Therapeutic Targets;2024-05-03